Document is current
Any future updates will be listed below
-
Authors
Sprave, Tanja
Gkika, Eleni
Verma, Vivek
Grosu, Anca-Ligia
Stoian, Raluca
-
Funding
Funding for this research was provided by:
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 14 July 2022
Accepted: 21 November 2022
First Online: 29 November 2022
Declarations
:
: The study was approved by the institutional ethical review committee of the Albert Ludwigs University of Freiburg (reference no. 389/19) and was per formed in accordance with the relevant guidelines and regulations. The need for patient informed consent was waived by the ethics committee of the Albert Ludwigs University of Freiburg.
: Not applicable.
: T. Sprave has received honoraria from Hologic outside the submitted work. T. Sprave had participated in an expert exchange regarding tumour bed marking and boost application in breast carcinoma. The other authors declare that they have no competing interests.
